Stockscreener 앱 받기
463.04
0.99%
-4.64
시간 외 거래:
463.04
전일 마감가:
$467.68
열려 있는:
$461.03
하루 거래량:
2.76M
Relative Volume:
0.98
시가총액:
$174.79B
수익:
$43.21B
순이익/손실:
$6.58B
주가수익비율:
26.78
EPS:
17.29
순현금흐름:
$6.17B
1주 성능:
-3.19%
1개월 성능:
+9.86%
6개월 성능:
-22.54%
1년 성능:
-25.53%
1일 변동 폭
$451.45
$464.10
1주일 범위
$451.45
$488.52
52주 변동 폭
$385.46
$627.88
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
463.04 | 176.55B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.09 | 141.18B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
535.54 | 42.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.50 | 32.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.45 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation - Yahoo Finance
Here’s Why Thermo Fisher Scientific (TMO) Traded Down in Q2 - Insider Monkey
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
Global G-Protein Coupled Receptors Market [2025-2032] - openPR.com
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific - Yahoo Finance
Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
5 Insightful Analyst Questions From Thermo Fisher’s Q2 Earnings Call - TradingView
Thermo Fisher Margins Feel The Weight Of Tariffs Even As China Trade Pressures Ease In Q2 - insights.citeline.com
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ... - Yahoo Finance
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - MSN
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - MSN
Thermo Fisher Scientific showcases diagnostics solutions designed to meet evolving global healthcare demands at ADLM 2025 - SelectScience
North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance
Is Thermo Fisher Scientific Inc. stock overvalued or undervaluedExpert Picks Outlook For Beginners - jammulinksnews.com
Thermo Fisher Scientific EVP Pettiti Sells 400 Shares at $479.98/Share. - AInvest
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts - Investing.com
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn - openPR.com
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth - MSN
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - 01net
Cell Reprogramming Market Future Business Opportunities - openPR.com
How many analysts rate Thermo Fisher Scientific Inc. as a “Buy”Outstanding risk-reward balance - jammulinksnews.com
Is Thermo Fisher Scientific Inc. a growth stock or a value stockExponential return rates - jammulinksnews.com
Thermo Fisher Scientific's (TMO) Q2 Outperformance and Revised Price Target: Is Now the Time to Buy? - AInvest
Refurbished Laboratory Equipment Market Top Companies Study - openPR.com
When is Thermo Fisher Scientific Inc. stock expected to show significant growthDiscover high-impact investment opportunities - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Thermo Fisher Scientific Inc. (TMO) Has Finally Got It Together, Says Jim Cramer - MSN
Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480 - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentFree Stock Index Interpretation - PrintWeekIndia
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference - Yahoo Finance
Fortune 500 Power Moves: Which executives gained and lost power this week, July 19-25, 2025 - Fortune
Thermo Fisher Unit Can’t Undo Executive’s $24 Million Bias Win - Bloomberg Law News
Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... - MarketScreener
Thermo Fisher Scientific Second Quarter 2025 Earnings: Beats Expectations - simplywall.st
Microplate Readers Market Is Booming So Rapidly 2025-2032 - openPR.com
Thermo Fisher Scientific Increases Accessibility to Research with the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - AZoM
ICP-MS System Market Key Players AnalysisPerkinElmer, Inc., - openPR.com
Stifel lowers Thermo Fisher Scientific stock price target to $583 on mixed outlook - Investing.com Canada
What analysts say about Thermo Fisher Scientific Inc. stock outlookRapid wealth multiplication - jammulinksnews.com
HSBC downgrades Thermo Fisher Scientific stock to Hold on growth concerns - Investing.com
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - StreetInsider
Thermo Fisher Scientific Inc. Ranks 19th in Trading Volume Despite 17.31% Stock Gain in Three Days - AInvest
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
UBS Maintains Neutral Rating for Thermo Fisher, Raises PT to $500 from $460 - AInvest
Thermo Fisher Scientific shares rise 2.73% intraday after announcing new electron microscopes and licensing agreement expansion. - AInvest
Thermo Fisher Scientific unveils new Orbitrap mass spectrometers - SelectScience
Thermo Fisher CFO to retire after decade, internal successor named - The Business Journals
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
0.23%
자본화:
|
볼륨(24시간):